Leptin receptor signaling in T cells is required for Th17 differentiation

Journal of Immunology

Volumn 194, Issue 11, 2015, Pages 5253-5260

  Reis, Bernardo S ^a   Lee, Kihyun ^a,d   Fanok, Melania H ^a,e   Mascaraque, Cristina ^a,f   Amoury, Manal ^a   Cohn, Lillian B ^a   Rogoz, Aneta ^a   Dallner, Olof S ^a   Moraes Vieira, Pedro M ^b   Domingos, Ana I ^c   Mucida, Daniel ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^d Weill Cornell Graduate School of Biomedical Sciences   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN RECEPTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; LEPTIN; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL INFILTRATION; CELL SURVIVAL; CITROBACTER RODENTIUM; COLITIS; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GENE EXPRESSION; LEPTIN DEFICIENCY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TH17 CELL; ANIMAL; AUTOIMMUNITY; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; ENTEROBACTERIACEAE INFECTION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELLS, CULTURED; CITROBACTER RODENTIUM; COLITIS; ENTEROBACTERIACEAE INFECTIONS; LEPTIN; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS;

EID: 84929649679     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402996     Document Type: Article

References (34)

1. Littman, D. R., and A. Y. Rudensky. 2010. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140: 845-858.
2. Basu, R., R. D. Hatton, and C. T. Weaver. 2013. The Th17 family: flexibility follows function. Immunol. Rev. 252: 89-103.
3. Mathis, D. 2013. Immunological goings-on in visceral adipose tissue. Cell Metab. 17: 851-859.
4. Friedman, J. M., and J. L. Halaas. 1998. Leptin and the regulation of body weight in mammals. Nature 395: 763-770.
5. Lord, G. M., G. Matarese, J. K. Howard, R. J. Baker, S. R. Bloom, and R. I. Lechler. 1998. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394: 897-901.
6. Mackey-Lawrence, N. M., and W. A. Petri, Jr. 2012. Leptin and mucosal immunity. Mucosal Immunol. 5: 472-479.
7. Howard, J. K., G. M. Lord, G. Matarese, S. Vendetti, M. A. Ghatei, M. A. Ritter, R. I. Lechler, and S. R. Bloom. 1999. Leptin protects mice from starvationinduced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J. Clin. Invest. 104: 1051-1059.
8. Gainsford, T., T. A. Willson, D. Metcalf, E. Handman, C. McFarlane, A. Ng, N. A. Nicola, W. S. Alexander, and D. J. Hilton. 1996. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc. Natl. Acad. Sci. USA 93: 14564-14568.
9. Yu, Y., Y. Liu, F. D. Shi, H. Zou, G. Matarese, and A. La Cava. 2013. Cutting edge: Leptin-induced RORgt expression in CD4+ T cells promotes Th17 responses in systemic lupus erythematosus. J. Immunol. 190: 3054-3058.
10. Cohen, P., C. Zhao, X. Cai, J. M. Montez, S. C. Rohani, P. Feinstein, P. Mombaerts, and J. M. Friedman. 2001. Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest. 108: 1113-1121.
11. Reis, B. S., A. Rogoz, F. A. Costa-Pinto, I. Taniuchi, and D. Mucida. 2013. Mutual expression of the transcription factors Runx3 and ThPOK regulates intestinal CD4∗ T cell immunity. Nat. Immunol. 14: 271-280.
12. Mangan, P. R., L. E. Harrington, D. B. O'Quinn, W. S. Helms, D. C. Bullard, C. O. Elson, R. D. Hatton, S. M. Wahl, T. R. Schoeb, and C. T. Weaver. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231-234.
13. Eberl, G., and D. R. Littman. 2004. Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+ cells. Science 305: 248-251.
14. Chuang, H. C., W. H. Sheu, Y. T. Lin, C. Y. Tsai, C. Y. Yang, Y. J. Cheng, P. Y. Huang, J. P. Li, L. L. Chiu, X. Wang, et al. 2014. HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat. Commun. 5: 4602.
15. Deng, J., Y. Liu, M. Yang, S. Wang, M. Zhang, X. Wang, K. H. Ko, Z. Hua, L. Sun, X. Cao, and L. Lu. 2012. Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis Rheum. 64: 3564-3573.
16. Yang, Y., J. Weiner, Y. Liu, A. J. Smith, D. J. Huss, R. Winger, H. Peng, P. D. Cravens, M. K. Racke, and A. E. Lovett-Racke. 2009. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206: 1549-1564.
17. Oestreich, K. J., S. E. Mohn, and A. S. Weinmann. 2012. Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile. Nat. Immunol. 13: 405-411.
18. Laurence, A., S. Amarnath, J. Mariotti, Y. C. Kim, J. Foley, M. Eckhaus, J. J. O'Shea, and D. H. Fowler. 2012. STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease. Immunity 37: 209-222.
19. Takahashi, R., S. Nishimoto, G. Muto, T. Sekiya, T. Tamiya, A. Kimura, R. Morita, M. Asakawa, T. Chinen, and A. Yoshimura. 2011. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-gamma and IL-17A production. J. Exp. Med. 208: 2055-2067.
20. Ray, J. P., H. D. Marshall, B. J. Laidlaw, M. M. Staron, S. M. Kaech, and J. Craft. 2014. Transcription factor STAT3 and type I interferons are corepressive insulators for differentiation of follicular helper and T helper 1 cells. Immunity 40: 367-377.
21. Basu, R., D. B. O'Quinn, D. J. Silberger, T. R. Schoeb, L. Fouser, W. Ouyang, R. D. Hatton, and C. T. Weaver. 2012. Th22 cells are an important source of IL- 22 for host protection against enteropathogenic bacteria. Immunity 37: 1061-1075.
22. Sonnenberg, G. F., L. A. Monticelli, M. M. Elloso, L. A. Fouser, and D. Artis. 2011. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34: 122-134.
23. Sanna, V., A. Di Giacomo, A. La Cava, R. I. Lechler, S. Fontana, S. Zappacosta, and G. Matarese. 2003. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. 111: 241-250.
24. Birsoy, K., A. Soukas, J. Torrens, G. Ceccarini, J. Montez, M. Maffei, P. Cohen, G. Fayzikhodjaeva, A. Viale, N. D. Socci, and J. M. Friedman. 2008. Cellular program controlling the recovery of adipose tissue mass: An in vivo imaging approach. Proc. Natl. Acad. Sci. USA 105: 12985-12990.
25. Kuraishy, A., M. Karin, and S. I. Grivennikov. 2011. Tumor promotion via injury- and death-induced inflammation. Immunity 35: 467-477.
26. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
27. Liu, X., Y. S. Lee, C. R. Yu, and C. E. Egwuagu. 2008. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J. Immunol. 180: 6070-6076.
28. Chen, Y., C. L. Langrish, B. McKenzie, B. Joyce-Shaikh, J. S. Stumhofer, T. McClanahan, W. Blumenschein, T. Churakovsa, J. Low, L. Presta, et al. 2006. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 116: 1317-1326.
29. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
30. Procaccini, C., V. De Rosa, M. Galgani, L. Abanni, G. Calì, A. Porcellini, F. Carbone, S. Fontana, T. L. Horvath, A. La Cava, and G. Matarese. 2010. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33: 929-941.
31. Yu, X., D. Rollins, K. A. Ruhn, J. J. Stubblefield, C. B. Green, M. Kashiwada, P. B. Rothman, J. S. Takahashi, and L. V. Hooper. 2013. TH17 cell differentiation is regulated by the circadian clock. Science 342: 727-730.
32. Wang, X., N. Ota, P. Manzanillo, L. Kates, J. Zavala-Solorio, C. Eidenschenk, J. Zhang, J. Lesch, W. P. Lee, J. Ross, et al. 2014. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514: 237-241.
33. Chen, H., O. Charlat, L. A. Tartaglia, E. A. Woolf, X. Weng, S. J. Ellis, N. D. Lakey, J. Culpepper, K. J. Moore, R. E. Breitbart, et al. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495.
34. Li, Z., G. Ceccarini, M. Eisenstein, K. Tan, and J. M. Friedman. 2013. Phenotypic effects of an induced mutation of the ObRa isoform of the leptin receptor. Mol. Metab. 2: 364-375.